Archive for May, 2014
Recent Rosacea Blog Posts
In September last year a trial was listed to assess whether cromolyn sodium ophthalmic solution 4% could improve the redness associated with rosacea. This trial was listed by Dr. Anna Di Nardo, who is a part of the UCSD and has received NRS funding in 2012 to research the link between Mast Cells and the […]
A paper published in the Georgian Medical News, and listed on PubMed details a study that concludes that Rutin Forte is an effective means for the treatment and prevention of erythematous rosacea. The supplement was included alongside regular rosacea therapy of topical and oral antibiotics. What is Rutin Forte? Rutin Forte is a nutritional supplement […]
Galderma has reached into its bag of trademarks and announced that Mirvaso will be known as ONRELTEA in Canada. Red Faced? Rosacea Sufferers Now Have a New Option Proven to Reduce Facial Redness Health Canada Approves The First and Only Topical Treatment Indicated for the Persistent Facial Erythema of Rosacea THORNHILL, ON, May 21, 2014 […]
Linda Stein Gold mentions in a video posted on Skin and Allergy News, referring to Galderma’s Ivermectin Cream ; Phase 3 Clinical Trials have completed, and FDA Approval is expected later this year (2014). This is great new for those who 1) want to try an approved treatment for demodex mites and 2) may not […]
Allergan have listed their Phase 3 trials details for AGN-199201, their Oxymetazoline based treatment, called AGN-199201, for the persistent red face associated with rosacea. Phase 3 trials like this one are interested in assessing the safety and efficacy of the active ingredient in a proposed treatment. Efficacy is proved by comparing the active treatment against […]
